Minerva Neurosciences Valuation
| NERV Stock | USD 2.55 0.07 2.82% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Minerva Neurosciences secures a last-minute Real Value of $4.64 per share. The latest price of the firm is $2.55. Our model forecasts the value of Minerva Neurosciences from analyzing the firm fundamentals such as Shares Owned By Insiders of 22.26 %, current valuation of 58.45 M, and Return On Equity of -6.75 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend buying undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Minerva Neurosciences' valuation include:
Price Book 2.6783 | Enterprise Value 58.4 M | Enterprise Value Ebitda 1.093 | Price Sales 1.868 | Forward PE 11.2108 |
Undervalued
Today
Please note that Minerva Neurosciences' price fluctuation is very risky at this time. Calculation of the real value of Minerva Neurosciences is based on 3 months time horizon. Increasing Minerva Neurosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Minerva Neurosciences is useful when determining the fair value of the Minerva stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Minerva Neurosciences. Since Minerva Neurosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Minerva Stock. However, Minerva Neurosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.55 | Real 4.64 | Target 11.0 | Hype 2.47 |
The real value of Minerva Stock, also known as its intrinsic value, is the underlying worth of Minerva Neurosciences Company, which is reflected in its stock price. It is based on Minerva Neurosciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Minerva Neurosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Minerva Neurosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Minerva Neurosciences helps investors to forecast how Minerva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Minerva Neurosciences more accurately as focusing exclusively on Minerva Neurosciences' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Minerva Neurosciences' intrinsic value based on its ongoing forecasts of Minerva Neurosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Minerva Neurosciences' closest peers. When choosing an evaluation method for Minerva Neurosciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Minerva Neurosciences Investments |
|
Minerva Valuation Trend
Knowing Minerva Neurosciences' actual value is paramount for traders to make sound investment determinations. Minerva Neurosciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Minerva Neurosciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Minerva Neurosciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Minerva Market Cap
Minerva Neurosciences is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 8.86 Billion. Minerva Neurosciences adds roughly 17.34 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Minerva Neurosciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Minerva Neurosciences's current stock value. Our valuation model uses many indicators to compare Minerva Neurosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Minerva Neurosciences competition to find correlations between indicators driving Minerva Neurosciences's intrinsic value. More Info.Minerva Neurosciences is considered to be number one stock in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 0.04 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Minerva Neurosciences is roughly 25.98 . Price To Book Ratio is likely to climb to -1.34 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Minerva Neurosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Minerva Neurosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Minerva Neurosciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Minerva Neurosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Minerva Neurosciences and how it compares across the competition.
About Minerva Neurosciences Valuation
The stock valuation mechanism determines the current worth of Minerva Neurosciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Minerva Neurosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Minerva Neurosciences based exclusively on its fundamental and basic technical indicators. By analyzing Minerva Neurosciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Minerva Neurosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Minerva Neurosciences. We calculate exposure to Minerva Neurosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Minerva Neurosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -31 K | -29.4 K | |
| Pretax Profit Margin | 0.04 | 0.04 | |
| Operating Profit Margin | 0.04 | 0.04 | |
| Net Profit Margin | 0.04 | 0.04 | |
| Gross Profit Margin | 0.00 | 0.00 |
8 Steps to conduct Minerva Neurosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Minerva Neurosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Minerva Neurosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Minerva Neurosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Minerva Neurosciences' revenue streams: Identify Minerva Neurosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Minerva Neurosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Minerva Neurosciences' growth potential: Evaluate Minerva Neurosciences' management, business model, and growth potential.
- Determine Minerva Neurosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Minerva Neurosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Minerva Neurosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Minerva Neurosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 6.5 M | |
| Forward Price Earnings | 11.2108 |
Minerva Neurosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Minerva Neurosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Minerva we look at many different elements of the entity such as Minerva's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Minerva Neurosciences' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Minerva Neurosciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Minerva Neurosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Minerva Neurosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Minerva Neurosciences' worth.When determining whether Minerva Neurosciences is a strong investment it is important to analyze Minerva Neurosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Minerva Neurosciences' future performance. For an informed investment choice regarding Minerva Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.61) | Return On Assets (0.26) | Return On Equity (6.75) |
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.